Brief: Halozyme Raises 2025 Revenue Estimates, Raises 2026 And Multi-Year Financial Guidance
28/01/2026 11:51
Jan 28 (Reuters) - Halozyme Therapeutics Inc HALO.O: HALOZYME RAISES 2025 REVENUE ESTIMATES, RAISES 2026 AND MULTI-YEAR FINANCIAL GUIDANCE Source text: ID:nPn9RGHJja Further company coverage: HALO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Halozyme Therapeutics
See all newsUS RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Halozyme wins court order to block Merck's injected Keytruda in select European markets (updated)
US STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
Halozyme wins court order to block Merck's injected Keytruda in select European markets